# TOFACITINIB

NDC: 70069-842
Generic name: TOFACITINIB
Labeler / Manufacturer: Somerset Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260603

FDA application: ANDA220137

## Active ingredients

- TOFACITINIB CITRATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70069-842"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70069-842
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2726c2b0-c763-4635-ac6b-4334c3a5a8bc